Literature DB >> 23546558

Availability of monitoring serum HBV DNA plus RNA during nucleot(s)ide analogue therapy.

Masataka Tsuge, Kazuaki Chayama.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23546558     DOI： 10.1007/s00535-013-0801-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  3 in total

1.  Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.

Authors:  Yi-Wen Huang; Kazuaki Chayama; Masataka Tsuge; Shoichi Takahashi; Tsuyoshi Hatakeyama; Hiromi Abe; Jui-Ting Hu; Chun-Jen Liu; Ming-Yang Lai; Ding-Shinn Chen; Sien-Sing Yang; Jia-Horng Kao
Journal:  Antivir Ther       Date:  2010

2.  Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine.

Authors:  Tsuyoshi Hatakeyama; Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Masataka Tsuge; Michio Imamura; Shoichi Takahashi; Yoshiiku Kawakami; Yoshifumi Fujimoto; Hidenori Ochi; Hiromi Abe; Toshiro Maekawa; Hiroiku Kawakami; Hiromi Yatsuji; Yasuyuki Aisaka; Hiroshi Kohno; Shiomi Aimitsu; Kazuaki Chayama
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

3.  Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.

Authors:  Masataka Tsuge; Eisuke Murakami; Michio Imamura; Hiromi Abe; Daiki Miki; Nobuhiko Hiraga; Shoichi Takahashi; Hidenori Ochi; C Nelson Hayes; Hiroyuki Ginba; Kazuhiro Matsuyama; Hiroiku Kawakami; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527
  3 in total
  3 in total

Review 1.  Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs.

Authors:  Fengmin Lu; Jie Wang; Xiangmei Chen; Dongping Xu; Ningshao Xia
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

Review 2.  Detectability and clinical significance of serum hepatitis B virus ribonucleic acid.

Authors:  Yi-Wen Huang; Kazuaki Chayama; Jia-Horng Kao; Sien-Sing Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

3.  Serum HBV RNA Dynamic and Drug Withdrawal Predictor Value in Patients With Chronic HBV Infection on Long-term Nucleos(t)ide Analogue (NA) Therapy.

Authors:  Yayun Liu; Jianya Xue; Wei Liao; Hongli Yan; Xuesong Liang
Journal:  J Clin Gastroenterol       Date:  2020-09       Impact factor: 3.174
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.